Institutions

On Clinical Trials Day, now more than ever, it’s important to recognize and thank those unsung heroes at the focal point of research: research sites and institutions. Read more:

The coronavirus pandemic has brought genetic research to the forefront. To address emerging issues, Advarra presents its first virtual symposium. Read more:

Strategies for convincing leadership to invest in the tools needed to optimize operations and inform strategic decision-making.

Recent regulations and policies have many institutions establishing policies and processes for working with an external sIRB. Read more:

We have addressed the most popular Q&A topics from our recent webinar on the research impact of COVID-19 in this blog post. Read more:

Everyone wants to be part of a strong work culture, but how does your organization get there? Check out three tips for building a stronger work culture.

The difference between “public” and “private” internet spaces has gained importance with the growing research use of internet and social media platforms as data sources. Read more:

Is your site prepared to participate in COVID-19 vaccine research? Registering an IBC ahead of time gives you an advantage. Read more:

Dr. Gelinas answers audience questions we weren’t able to address during the webinar.

Many studies do not accrue subjects at the site level, which contributes to a significant amount of waste of staff time and monetary resources. Read more:

If the clinical development time of a new treatment is to ever decrease, reducing the time in study activation is necessary so actual research can be done.

Research doesn’t just inform medical treatment; it informs public health and public policy, and it helps explain human behaviors. Read more: